Bridgewater, MA -- (SBWIRE) -- 04/02/2013 -- The Automated StockConsultant screener has found provider of pharmaceuticals for serious diseases and medical conditions BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) a biotech stock with a confirmed breakout to new highs.
BMRN stock price is up 2.4% to 63.09 and has a confirmed breakout above 62.6 and the month-long consolidation, with a target of 66.52 for a short-term gain of 5.4%.
Read the full BMRN StockConsultant Report
StockConsultant.com provides automated stock consulting reports and an advanced screener on over 6000 US equities. Each detailed stock report contains easy to use technical analysis indicators, charts, and news to fine tune stock entry and exit price levels. A daily "Stocks to Watch" list, real-time portfolio (show up to 35 stock charts simultaneously) and keyboard controlled QuickCharts complete the tools.
Disclosure: StockConsultant.com and its employees are not registered investment advisors and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Please check with a registered investment advisor before making any investment decisions. For our full disclaimer please visit www.stockconsultant.com/disclaimerpage.html
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)